IRON

Disc Medicine Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↓ 0/10
  • Momentum↓ 4/10
Disc Medicine sales and earnings growth
IRON Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -34.42%
  • FCF Y/Y↓ -97.16%
Disc Medicine gross and profit margin trends
IRON Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↓ -36.40%
Disc Medicine net debt vs free cash flow
IRON Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -53.8

Disc Medicine stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗